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ABSTRACT 
Mutations in COL4A1, encoding one of the six collagen type IV proteins, cover a wide spectrum of 
autosomal dominant overlapping phenotypes including porencephaly, small-vessel disease and 
hemorrhagic stroke, leukoencephalopathy, hereditary angiopathy with nephropathy, aneurysms and 
muscle cramps (HANAC) syndrome, and Walker-Warburg syndrome. Over 50 mutations are known, 
mainly being missense changes. Intra- and inter-familial variability has been reported.  
We studied two Italian families in which the proband had a clinical diagnosis of COL4A1-related 
disorder. We found two novel mutations (c.1249 G>C; p.Gly417Arg and c.2662G>C; p.Gly888Arg). 
Both involved highly conserved amino acids and were predicted as being deleterious by bioinformatics 
tools. The c.1249 G>C (p.Gly417Arg) segregated in four subjects with variable neurological 
phenotypes, namely leukoencephalopathy with muscle symptoms, brain small-vessel disease and mild 
infantile encephalopathy. A fourth case was a carrier of the mutation without any neurological 
symptoms and a MRI with aspecific white matter anomalies. The c.2662G>C (p.Gly888Arg) mutation 
was de novo in the proband. After a temporary motor impairment at age 14, the subject complained of 
mild imbalance at age 30, during the third trimester of her twin pregnancy, when an anomaly of the left 
brain hemisphere was documented in one fetus. Both her male dizygotic twins presented a severe motor 
delay, early convulsions, and leukoencephalopathy, and were carriers of the mutation.  
In summary, we confirm that high intra-familial variability of COL4A1 mutations with very mild 
phenotypes, the apparent incomplete penetrance, and de novo changes may become a “dilemma” for 
clinicians and genetic counsellors. 
 
 3 
 
1. Introduction 
Collagen type IV is a multimeric protein expressed almost exclusively in the basal membrane [1]. In 
humans, it is encoded by six paralogous genes: COL4A1 to COL4A6 [2]. Each gene encodes for one of 
six different chains (alpha1 to alpha6), which assemble to form three heterotrimers, namely α1α1α2, 
α3α4α5 and α5α5α6. Whereas α1 and α2 chains are ubiquitously expressed, the others are tissue- or 
developmental time-specific [3]. 
Mutations in each COL4A gene have been found in human diseases; COL4A3, COL4A4 and COL4A5 
have been associated with Alport syndrome [4]; genomic rearrangements involving COL4A5 and 
COL4A6 (located head-to-head on chromosome X) have been found in families with diffuse 
leiomyomatosis (a smooth muscle tumor), and Alport syndrome [5, 6]; COL4A6 mutations are 
responsible for X-linked deafness [7]. More recently, mutations in COL4A1 have been identified in a 
wide range of diseases, including porencephaly [8, 9], familial and sporadic small-vessel disease and 
hemorrhagic stroke [10-12], leukoencephalopathy [13], hereditary angiopathy with nephropathy, 
aneurysms and muscle cramps (HANAC) syndrome [14], Walker-Warburg syndrome [15], and isolated 
ophthalmological anomalies [13, 16]. It has been proposed that this spectrum of signs and symptoms 
may be grouped under the name of COL4A1-related disorders [17], thus indicating a single disease with 
great variability in expressivity and age at onset. Finally, COL4A2 has been found to be mutated in the 
autosomal dominant porencephaly type 2 [18]. 
 
2. Subjects and Methods 
We studied two independent Italian families with a clinical suspicion of COL4A1-related disorders 
(Figure 1). Informed consent was obtained from all participants in the study or their legal 
representatives; the study was approved by the internal ethics committee of the Department of Medical 
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Sciences, University of Torino, Italy. All coding exons and flanking intron boundaries of COL4A1 
(NM_001845) and COL4A2 (NM_001846) were amplified by PCR from blood-extracted genomic 
DNA (Qiagen, Mannheim, Germany), and Sanger sequenced (Life Technologies, Carlsbad, CA, USA). 
Mutation pathogenicity was evaluated using bioinformatics tools (Figure 2). 
We genotyped local healthy subjects by PCR (Exon 21: 5’-ttgcaggcctccctgtacc and 5’-
gcccagggggcccaggggaac;  Exon 33: 5’-tgatccattcaagttcccagtgt and 5’-ccaagtggcatcgagaaatagac), 
restriction digestion analysis and agarose gel electrophoresis. A total of 550 chromosomes were 
analyzed for the c.1249G>C mutation (exon 21) and 522 for c.2662G>A mutation (exon 33). 
Digestions were performed with TaqI for exon 21 and SmaI for exon 33. For exon 21, the digestion 
yields a 156 bp fragment for the wild-type allele and two fragments of 134 bp and 22 bp in the mutated 
allele. For exon 33, the digestion yields two fragments of 468 bp and 113 bp in the wild-type allele and 
a fragment of 581 bp in the mutated allele. 
 
3. Results 
3.1 Clinical data  
3.1.1 Family LEU-1-TO  
The proband, a 50 yr-old woman with a maternal family history of stroke, had a first cerebral 
hemorrhage at age 45, which was mainly endoventricular (Table 1, Figure 1A). Cerebral angiography 
demonstrated a small aneurysm of the anterior communicating artery. She subsequently suffered from a 
retinal hemorrhage. A retinography demonstrated marked tortuosity of retinal vessels (Figure 1B). At 
age 47, she presented an acute left hemiparesis after repeated sneezing. MRI showed periventricular 
bleeding and a diffuse signal abnormality of the supratentorial white matter (Figure 1C-D). 
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Proband mother displayed mild perinatal hemiparesis and had a history of epileptic seizures since the 
age of 3 yrs., incompletely controlled by antiepileptic therapy. She had, however, never experienced 
stroke. Clinical history was therefore compatible with an idiopathic form of perinatal encephalopathy.  
Proband sister (III-4) complained of muscle cramps and a mild impairment of the right leg since 
adolescence. General and metabolic work-up resulted as being normal with Creatine Phospho Kinase 
(CPK) at the upper level of the normal range. MRI showed diffuse leukoencephalopathy (Figure 1G) 
and retinography demonstrated a mild retinal vessel tortuosity (Figure 1F).  
MRI also showed a diffuse leukoencephalopathy in the proband and in the mother (III-1, II-2), and a 
small porencephalic periventricular lesion in II-2.  
Proband brother (III-3) was completely asymptomatic at age 30 and had an unremarkable clinical 
history except for two episodes of spontaneous pneumothorax in his youth. MRI showed just a few 
small non-specific T2 hyperintensities of the supratentorial white matter (Figure 1E). CPK was normal. 
Brain angio MR and ophthalmological examination were not performed. 
 
3.1.2 Family LEU-2-TO  
The proband was a 34 yr-old woman, the eldest of three siblings, born from non-consanguineous 
neurologically-healthy parents. She had a history of congenital glaucomas and cataracts (Table 1, 
Figure 1A).  
At age 14, the patient presented a sudden and reversible motor impairment, which was not further 
investigated. At age 30, during the third trimester of her twin pregnancy, she started complaining mild 
imbalance and gait disorder. At that time, an anomaly of the left brain hemisphere was documented in 
one fetus by ultrasounds. The patient underwent an elective caesarian section, the decision of which 
was taken after 1 month of clinical worsening, represented by repeated episodes of vomiting with 
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weight loss and stepwise gait unbalance. Her blood pressure and routine blood examinations were 
normal. Soon after the delivery (~ 1 hour), she presented right hemiparesis with dystonic posture of the 
upper arm and early hypertonus of both the right arm and the right leg. The CT scan showed a left 
parietal hemorrhage and a diffuse hypointensity of supra- and infra-tentorial white matter. The MRI 
confirmed a severe leukoencephalopathy and displayed multiple supra and infra-tentorial micro-
hemorrhages, together with lacunar infarcts (Figure 1H-I). Cerebral angiography revealed diffuse 
anomalies of the carotid axis; specifically, focal areas of vessel narrowing interspersed with 
pseudoaneurysmatic dilatations of both cavernous segments, and the major findings were two small 
(less than 1 mm) left carotid-ophthalmic and left carotid siphon aneurysms. The posterior vascular axis 
was relatively free from anomalies. 
Both male twins of the patient presented severe motor delay and early convulsions. MRI confirmed 
severe encephalopathy in both children (Figure 1J). At age 6 years, twin A presented with severe 
psychomotor delay with tetraparesis, absence of speech and severe intellectual disability; twin B had 
epileptic encephalopathy, which was partially non-respondent to therapy. Twin B can walk but has 
never acquired complete language skills. 
 
3.2 Genetic findings 
Sequencing of COL4A1 revealed the c.1249 G>C mutation in exon 21 (p.Gly417Arg) in family LEU-
1-TO, and the c.2662G>A mutation in exon 33 (p.Gly888Arg) in family LEU-2-TO (Figure 1A). 
Both mutations were novel, and not reported as polymorphisms in the 1000 Genomes 
(www.1000genomes.com), dbSNP138 (www.ncbi.nlm.nih.gov/projects/snp) and HapMap 
(www.hapmap.com) databases. To exclude population stratification artifacts, we screened, by 
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restriction enzyme assays, a cohort of local controls (more than 500 chromosomes) and the two variants 
were not identified.  
Both mutations involved alterations of highly conserved glycine residues within a Gly-X-Y repeat of 
the triple helical rod domain, and were predicted to be likely pathogenic by different bioinformatics 
tools (see Fig. 2).  
 
4. Discussion  
COL4A1-related disorders cover a spectrum of autosomal dominant overlapping phenotypes including 
porencephaly type 1 (OMIM #175780), brain small-vessel disease with hemorrhage (OMIM #607595) 
and HANAC (OMIM #611773). Intra- and inter-familial variability are common findings in all 
COL4A1- related disorders (http://www.ncbi.nlm.nih.gov/books/NBK7046/). 
We found two novel mutations (c.1249G>C; p.Gly417Arg and c.2662G>A; p.Gly888Arg) confirming 
the phenotype variability and an apparent incomplete penetrance of these diseases. Their pathogenicity 
is strongly supported by bioinformatics predictions including the physical-chemical properties of the 
amino acid changed, the evolutionary conservation, and the lack of known SNPs at the mutant site. 
Indeed, 42 of the 46 pathogenic missense mutations described in COL4A1 affect a glycine within Gly-
X-Y repeats, suggesting that this amino acid change is not tolerated. Moreover, Gly-to-Arg mutations 
have been shown to be pathogenic in the C.elegans Col4a1 orthologue [19, 20] and in human COL4A5 
[21].  Finally, the mutation in family LEU-2-TO is de novo, a strong indicator of pathogenicity [22].  
A total of 58 mutations have been described in COL4A1, the majority of which affect the triple-helical 
central rod domain (88%; Figure 2). HANAC is almost exclusively associated with mutations located 
in the initial third of the rod domain (exons 9-25), with a cluster of mutations in exons 24-25. A 
genotype-phenotype correlation is absent for mutations that affect the remaining part of the rod domain 
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(exons 26-48) [2]. The c.1249G>C (p.Gly417Arg) mutation was found to be associated with three 
different clinical presentations [leukoencephalopathy with muscle symptoms (III-4), brain small-vessel 
disease (III-1), and mild infantile encephalopathy (II-2)], with the absence of a neurologic phenotype in 
one subject.  
In the LEU-2-TO family, c.2662G>A (p.Gly888Arg) resulted in a severe antenatal intracerebral 
hemorrhage leading to porencephaly in two cases, a rare finding reported in literature without a strict 
correlation with mutation type or location [23-25]. 
Both probands in the two families present intracerebral aneurysms involving the carotid axis, a 
distinctive feature of HANAC phenotype, but also present at various degrees in other COL4A1-related 
phenotypes. In family LEU-1-TO, aneurysms are combined with a dysplastic change of the 
artery as previously reported [26]. 
Both genetic and/or environmental modifiers could be responsible for this intra-familial variability. 
Among these, mechanical traumas may have a role in triggering an acute hemorrhage in agreement 
with other reports, as was the case for III-1 in family LEU-1-TO (repeated sneezing) [27, 28]. In 
proband II-3 (LEU-2-TO), we speculate that physical stress and unknown factors present in late 
pregnancy caused one or more episode of subacute stroke. These lead to clinical worsening in the third 
trimester followed by a more severe hemorrhage and a right hemiparesis soon after the caesarian 
section. 
We suggest a diagnosis of COL4A1-related disorders should be suspected in cases with compatible 
clinics/neuroradiology, even in the absence of a familial history. For instance, a de novo mutation can 
be present (e.g., c.2662G>A), or the variable expression with age of onset and/or the lack of detailed 
clinical examination may mimic incomplete penetrance (e.g., c.1249G>C) [29]. These disorders 
represent a challenge for genetic counselling: there is a 50% risk of transmitting the genetic defect to a 
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child, but establishing the phenotype in a newborn is impossible due to the variability in disease 
expression.  
 
 
4.1 Conclusions 
We describe two novel COL4A1 missense mutations and  confirm the high intra-familial variability of 
COL4A1-related disorders with very mild phenotypes and apparent incomplete penetrance that, 
together with de novo events, may represent a “dilemma” for clinicians and genetic counsellors. 
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FIGURE LEGEND 
Figure 1. Genealogic trees, mutation analysis, MRI scans and retinography. (A) LEU-1-TO and 
LEU-2-TO family trees. Lower panels: sequence electropherograms showing COL4A1 mutations. (B) 
Fluorescein angiography showing typical retinal arteriolar tortuosity in subject LEU-1-TO:III-1 
(arrows). (C) axial fluid-attenuated inversion recovery (FLAIR) image shows a diffuse periventricular 
leukoencephalopathy; (D) axial T2 gradient echo shows multiple micro-bleeds (arrows). (E) axial T2 
gradient echo in LEU-1-TO:III-3 demonstrates small hyperintensity in subcortical white matter 
(arrows). (F) Fluorescein angiography shows mild retinal vessel tortuosity (arrow) in LEU-1-TO:III-4. 
(G) axial fluid-attenuated inversion recovery (FLAIR) image shows a diffuse periventricular 
leukoencephalopathy in LEU-1-TO:III-4. (H) Sagittal FLAIR image shows a diffuse periventricular 
leukoencephalopathy with some lacunar infarcts in LEU-2-TO:II-3 (arrow); (I) axial T2 gradient echo 
demonstrates multiple micro-hemorrhages (arrows); (J) axial T2 turbo-spin echo shows an insular 
encephalomalacia with peripheral low signal intensity due to an old parenchymal hemorrhage (arrow). 
 
Figure 2. COL4A1 mutations. (A) and (B) The p.Gly417Arg and p.Gly888Arg changes are shown. 
Both mutations affected residues highly conserved  in vertebrates as shown by the “Multiz Alignment 
of 100 Vertebrates” track of the UCSC genome browser (www.genome.ucsc.edu). The mutation 
pathogenicity was assessed using eight different software. (C) The COL4A1 protein structure is 
showed with the amino-terminal 7S domain, the central collagen triple helical domain, and the 
carboxy-terminal NC1 domain. Mutations in COL4A1 are in red when associated with porencephaly. 
Black lines indicate the two novel mutations reported in this paper (A and B). 
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